Estimate of Brazilians Under Secondary Prevention of Cardiovascular Events Who Do Not Achieve LDL Cholesterol Targets with Lipid-Lowering Therapy. [PDF]
Arq Bras CardiolBraga A +5 more
europepmc +1 more source
[The Medical Nutrition Research Unit: towards the new challenges of translational research]. [PDF]
Rev Med Inst Mex Seguro SocMaldonado-Hernández J.
europepmc +1 more source
A influência da atenção farmacêutica na adesão ao tratamento das Dislipidemias
Considerando que as dislipidemias são distúrbios metabólicos que afetam os níveis de lipídios no sangue, como colesterol e triglicerídeos, e aumentam significativamente o risco de doenças cardiovasculares.
Duarte, Karine Watanabe de Brito +4 more
core
[Changes in hypertensive control 2020-2021 in a family medicine unit]. [PDF]
Rev Med Inst Mex Seguro SocTetetla-Castro D +2 more
europepmc +1 more source
[Comprehensive approach to comorbidities in COPD: expert recommendations]. [PDF]
Open Respir Archde Miguel-Díez J +4 more
europepmc +1 more source
[Dyslipidemia in high cardiovascular risk patients. Initial results from the REMEXDIS-IMSS study]. [PDF]
Rev Med Inst Mex Seguro SocMachuca-Loeza MG +6 more
europepmc +1 more source
ATORVASTATIN EFFICIENCY IN CORRECTION OF DISLIPIDEMIA
The Bulletin of Contemporary Clinical Medicine, 2008 Svetlana N. Orekhova, Nail B. AMirov
openaire +1 more source
Heart Rate Reduction after Effort Test Is Higher in Physically Active Adults without Familial Cardiovascular Risk Factor. [PDF]
Arq Bras CardiolDourado LA +5 more
europepmc +1 more source